Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutrabolt is a global active health and wellness company specializing in sports nutrition and performance energy products. The company operates primarily in the consumer health and wellness market rather than pharmaceutical/biotech. Major brands include C4 (one of the fastest-growing energy drink brands in the United States and #1 selling global pre-workout brand), XTEND (America's #1 BCAA brand), and Cellucor (award-winning sports nutrition brand). Products are distributed through company-owned DTC platforms, Amazon, third-party marketplaces, and major retailers including Walmart, Target, 7-Eleven, Walgreens, Kroger, H-E-B, Wawa, Publix, GNC, and the Vitamin Shoppe. The company is on pace to exceed $1 billion in annual revenue on a consolidated basis as of 2025. Nutrabolt acquired Scivation in 2017, adding the XTEND brand to its portfolio. In 2022, the company committed to Pledge 1% for social impact. Recognized as one of the 100 Best Companies to Work For and Great Place to Work certified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutrabolt.